Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Bioharvest Sciences Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −2 vs. Q4 2025
- Shares held
- 1.70M
- +67.5K (+4.1%) vs. Q4 2025
- Total value
- $7.38M
- −$1.10M (−12.9%) vs. Q4 2025
- New holders
- 2
- 4 more added
- Sold out
- 4
- 5 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $4.80M |
| Q1 2026 | 20 | $7.38M |
| Q4 2025 | 22 | $8.48M |
| Q3 2025 | 9 | $2.44M |
| Q2 2025 | 8 | $724.7K |
| Q1 2025 | 8 | $802.6K |
| Q4 2024 | 6 | $545.4K |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Bioharvest Sciences Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federation des caisses Desjardins du Quebec | 76 | $325 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 154 | $657 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 628 | $2.73K | 0.00% | −34,605−98.2% | Reduced |
| UBS Group AG | 629 | $2.73K | 0.00% | −544−46.4% | Reduced |
| Royal Bank of Canada | 3,009 | $13.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,250 | $14.1K | 0.00% | 00.0% | Unchanged |
| Vident Advisory, LLC | 11,576 | $50.2K | 0.00% | +11,576 | New |
| Geode Capital Management, LLC | 11,811 | $51.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 13,083 | $56.8K | 0.00% | −14,915−53.3% | Reduced |
| Citadel Advisors LLC | 14,753 | $64.0K | 0.00% | −614−4.0% | Reduced |
| Susquehanna International Group, LLP | 16,394 | $71.2K | 0.00% | +1,657+11.2% | Added |
| TD Waterhouse Canada Inc. | 23,827 | $101.7K | 0.00% | +11,785+97.9% | Added |
| Silverberg Bernstein Capital Management LLC | 26,099 | $113.3K | 0.06% | +26,099 | New |
| XTX Topco Ltd | 29,649 | $128.7K | 0.00% | −3,626−10.9% | Reduced |
| King Luther Capital Management Corp | 40,000 | $173.6K | 0.00% | 00.0% | Unchanged |
| Magnus Financial Group LLC | 55,000 | $238.7K | 0.02% | 00.0% | Unchanged |
| Evercore Wealth Management, LLC | 139,470 | $605.3K | 0.01% | 00.0% | Unchanged |
| True North Advisors, LLC | 168,013 | $729.2K | 0.08% | +133,085+381.0% | Added |
| Thompson Siegel & Walmsley LLC | 386,759 | $1.68M | 0.03% | +12,042+3.2% | Added |
| Alyeska Investment Group, L.P. | 757,064 | $3.29M | 0.01% | 00.0% | Unchanged |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −27,065−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −21,235−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −14,632−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,556−100.0% | Sold out |